Albuvirtide

DB15166InvestigationalProtein Based Therapies

Albuvirtide is under investigation in clinical trial NCT03719664 (Albuvirtide and 3BNC117 as Long-Acting Maintenance Therapy in Virologically Suppressed Subjects).

Mechanism: Pharmacologically active on Env polyprotein
Curator reviewed
Also known as: Labuvirtide

Resolves to

Compound

UNIIMG9PC54E43CAS1417179-66-8

Clinical / RWD

ATCJ05AX33

Targets

Q53I07gp41

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

7Clinical trialsPhase, status and sponsor resolved per trial

1Marketed productAcross 1 country and 1 labeller

1ATC codeIncluding every combination product, plus 9 drug categories

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with Albuvirtide, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account